Scott Solomon | BiotechTV

top of page

Sep 1

Dr. Scott Solomon, PI of Bayer's FINEARTS-HF study of KERENDIA, discusses using this non-steroidal MRA in heart failure at the ESC Congress

He describes the results of this study, which tested KERENDIA in patients with mildly reduced or preserved ejection fraction.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE